<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The study was conducted in a tertiary referral teaching hospital </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 35 women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> were treated with low-dose enoxaparin and aspirin as soon as pregnancy was confirmed </plain></SENT>
<SENT sid="3" pm="."><plain>The outcome of pregnancy was analysed </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> rate was 7/35 (20%) whereas the live birth rate was 28/35 (80%) </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, low-dose (20 mg) enoxaparin in conjunction with low-dose aspirin treatment produced encouraging results </plain></SENT>
<SENT sid="6" pm="."><plain>The findings in this study suggest that there is a case for randomized controlled trials to compare low-dose (20 mg) enoxaparin with higher doses </plain></SENT>
</text></document>